
Limbrel Linked to Possible Fatal Adverse Events

Efficacy Studied Following Accelerated Drug Approvals
Flimsy Evidence Behind Many FDA Approvals
DEA Proposes Cutting Production of Come Opioids

Rheumatologists Respond to Prescription Opioid Analgesic Crisis

FDA Drug Labeling, Approval Process Help Minimize Lawsuits Against Pharmaceutical Companies
As Biosimilars Hit, EU Pharma Warns against Blanket Prescribing
ACR Releases New Position Statements on Site of Service & Compounding

Insights into Drug-Related Interactions in Older Adults
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 19
- Next Page »